Cargando…

Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen

Sex steroids play a key role in bone turnover and preserving BMD; hence, gender‐affirming hormone treatment (HT) in transgender people affects bone metabolism. Most studies have looked into the effect of HT on changes in BMD; however, they do not provide insights into changes in bone metabolism caus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlot, Mariska C, Wiepjes, Chantal M, de Jongh, Renate T, T’Sjoen, Guy, Heijboer, Annemieke C, den Heijer, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852079/ https://www.ncbi.nlm.nih.gov/pubmed/31099910 http://dx.doi.org/10.1002/jbmr.3762

Ejemplares similares

Bone Safety During the First Ten Years of Gender‐Affirming Hormonal Treatment in Transwomen and Transmen
por: Wiepjes, Chantal M, et al.
Publicado: (2018)

Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen
por: Scheres, Luuk J.J., et al.
Publicado: (2021)

Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
por: Wiepjes, Chantal M, et al.
Publicado: (2019)

The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
por: Schutte, Moya H., et al.
Publicado: (2022)

Development of Hip Bone Geometry During Gender‐Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty
por: van der Loos, Maria ATC, et al.
Publicado: (2021)

Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection
por: Vlot, Mariska C., et al.
Publicado: (2018)

Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
por: Matthys, Imke, et al.
Publicado: (2021)

Serum brain-derived neurotrophic factor (BDNF) is not regulated by testosterone in transmen
por: Auer, Matthias K., et al.
Publicado: (2016)

Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy
por: Collet, Sarah, et al.
Publicado: (2022)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

Brain connectivity dynamics in cisgender and transmen people with gender incongruence before gender affirmative hormone treatment
por: Uribe, Carme, et al.
Publicado: (2021)

The Role of Estrone in Feminizing Hormone Treatment
por: Tebbens, Marieke, et al.
Publicado: (2021)

The ENIGI (European Network for the Investigation of Gender Incongruence) Study: Overview of Acquired Endocrine Knowledge and Future Perspectives
por: Cocchetti, Carlotta, et al.
Publicado: (2022)

Change in grip strength in trans people and its association with lean body mass and bone density
por: Scharff, Miranda, et al.
Publicado: (2019)

SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
por: Defreyne, Justine, et al.
Publicado: (2020)

Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty
por: van der Loos, Maria A T C, et al.
Publicado: (2021)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Gender affirming hormonal treatment in Danish transgender persons: A nationwide register‐based study
por: Glintborg, Dorte, et al.
Publicado: (2022)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

OR25-4 Modulatory Effects of Estradiol on the Resting-State Functional Connectivity in Transwomen Following Gender Affirming Surgery
por: Schneider, Maiko, et al.
Publicado: (2019)

ESSM Position Statement “Sexual Wellbeing After Gender Affirming Surgery”
por: Özer, Müjde, et al.
Publicado: (2021)

Gender, Work, and Health for Trans Health Providers: A Focus on Transmen
por: MacDonnell, Judith A., et al.
Publicado: (2012)

Short‐Term Glucocorticoid Treatment Reduces Circulating Sclerostin Concentrations in Healthy Young Men: A Randomized, Placebo‐Controlled, Double‐Blind Study
por: Jacobsson, Merel, et al.
Publicado: (2020)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

Abstract 142: Prevalence of Psychosocial and Body Image Distress Among Transmen Seeking Gender Mastectomies
por: Kirsch, Michael J., et al.
Publicado: (2019)

Serum sclerostin is negatively associated with insulin sensitivity in obese but not lean women
por: Aznou, Anouar, et al.
Publicado: (2021)

Mapping evidence on the effects of gender-affirming hormone therapy on the hard and soft tissues of the craniofacial complex in transgender people: a protocol for a scoping review
por: Van den Bosch, M. F., et al.
Publicado: (2021)

Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study
por: de Nie, Iris, et al.
Publicado: (2021)

Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy
por: Klaver, Maartje, et al.
Publicado: (2021)

Magnetic Resonance Spectroscopy in Gender Dysphoria
por: Collet, Sarah Marie, et al.
Publicado: (2021)

A Web-Based Study of HIV Prevention in the Era of Pre-Exposure Prophylaxis Among Vulnerable HIV-Negative Gay and Bisexual Men, Transmen, and Transwomen Who Have Sex With Men: Protocol for an Observational Cohort Study
por: Nash, Denis, et al.
Publicado: (2019)

Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective?
por: Nelson, Michael D., et al.
Publicado: (2016)

OR27-05 Sexual Desire Changes in Transgender Individuals upon Initiation of Hormone Treatment; Results from the Longitudinal ENIGI Study
por: Defreyne, Justine, et al.
Publicado: (2020)

SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study
por: Yaish, Iris, et al.
Publicado: (2023)

Excision and Primary Anastomosis for Isolated, Short, Anastomotic Strictures in Transmen
por: Verla, Wesley, et al.
Publicado: (2020)

Characterization of the (1)H-MRS Metabolite Spectra in Transgender Men with Gender Dysphoria and Cisgender People
por: Collet, Sarah, et al.
Publicado: (2021)

Towards Full Citizenship: Correlates of Engagement with the Gender Identity Law among Transwomen in Argentina
por: Socías, María Eugenia, et al.
Publicado: (2014)

Gender Affirmation Surgery
por: Selvaggi, Gennaro, et al.
Publicado: (2018)

Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women
por: de Nie, Iris, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2vanei9tv3a21a274llact03j2